{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:58:15Z","timestamp":1792155495486,"version":"4.4.0"},"publisher-location":"Berlin, Heidelberg","reference-count":68,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662463437","type":"print"},{"value":"9783662463444","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/7854_2013_238","type":"book-chapter","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T01:19:14Z","timestamp":1377220754000},"page":"3-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Clinical Aspects of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Rhia","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"issue":"3","key":"238_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1034\/j.1399-0004.2001.600305.x","volume":"60","author":"EW Almqvist","year":"2001","unstructured":"Almqvist EW, Elterman DS, MacLeod PM et al (2001) High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clin Genet 60(3):198\u2013205","journal-title":"Clin Genet"},{"issue":"4","key":"238_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4(4):398\u2013403","journal-title":"Nat Genet"},{"issue":"1","key":"238_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM et al (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63(1):66\u201372","journal-title":"Neurology"},{"issue":"6","key":"238_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrn1926","volume":"7","author":"C Ballard","year":"2006","unstructured":"Ballard C, Howard R (2006) Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci 7(6):492\u2013500","journal-title":"Nat Rev Neurosci"},{"issue":"7679","key":"238_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(70)92119-7","volume":"2","author":"A Barbeau","year":"1970","unstructured":"Barbeau A (1970) Parental ascent in the juvenile form of Huntington\u2019s chorea. Lancet 2(7679):937","journal-title":"Lancet"},{"key":"238_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00012","author":"KM Biglan","year":"2013","unstructured":"Biglan KM, Zhang Y, Long JD et al (2013) Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci. doi:10.3389\/fnagi.2013.00012","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"238_CR7","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205(8):1869\u20131877","journal-title":"J Exp Med"},{"issue":"2","key":"238_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1517\/14656566.8.2.141","volume":"8","author":"RM Bonelli","year":"2007","unstructured":"Bonelli RM, Hofmann P (2007) A systematic review of the treatment studies in Huntington\u2019s disease since 1990. Expert Opin Pharmacother 8(2):141\u2013153","journal-title":"Expert Opin Pharmacother"},{"key":"238_CR9","unstructured":"Craufurd D, Snowden J (2002) Neuropsychological and neuropsychiatric aspects of Huntington\u2019s disease. In: Bates GP, Harper P, Jones L (eds) Huntington\u2019s disease, 3rd edn. Oxford University Press, Oxford, pp 62\u201394"},{"issue":"12","key":"238_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/jmg.29.12.915","volume":"29","author":"D Craufurd","year":"1992","unstructured":"Craufurd D, Tyler A (1992) Predictive testing for Huntington\u2019s disease: protocol of the UK Huntington\u2019s Prediction Consortium. J Med Genet 29(12):915\u2013918","journal-title":"J Med Genet"},{"key":"238_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304636","author":"SJ Evans","year":"2013","unstructured":"Evans SJ, Douglas I, Rawlins MD et al (2013) Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry. doi:10.1136\/jnnp-2012-304636","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"238_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/01.WNL.0000032255.75650.C2","volume":"59","author":"C Goizet","year":"2002","unstructured":"Goizet C, Lesca G, D\u00fcrr A et al (2002) Presymptomatic testing in Huntington\u2019s disease and autosomal dominant cerebellar ataxias. Neurology 59(9):1330\u20131336","journal-title":"Neurology"},{"issue":"4","key":"238_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.amjopharm.2010.08.006","volume":"8","author":"DR Guay","year":"2010","unstructured":"Guay DR (2010) Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother 8(4):331\u2013373","journal-title":"Am J Geriatr Pharmacother"},{"issue":"5940","key":"238_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM et al (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306(5940):234\u2013238","journal-title":"Nature"},{"key":"238_CR15","unstructured":"Harper P (2002) The epidemiology of Huntington\u2019s disease. In: Bates GP, Harper P, Jones L (eds) Huntington\u2019s disease, 3rd edn. Oxford University Press, Oxford, pp 3\u201327"},{"issue":"8","key":"238_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jmg.37.8.567","volume":"37","author":"PS Harper","year":"2000","unstructured":"Harper PS, Lim C, Craufurd D (2000) Ten years of presymptomatic testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Disease Prediction Consortium. J Med Genet 37(8):567\u2013571","journal-title":"J Med Genet"},{"issue":"6","key":"238_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jnnp-2011-301732","volume":"83","author":"DL Harrington","year":"2012","unstructured":"Harrington DL, Smith MM, Zhang Y et al (2012) Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 83(6):612\u2013619","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"238_CR18","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington G (1872) On chorea. Med Surg Report: Weekly J 26(15):317\u2013321","journal-title":"Med Surg Report: Weekly J"},{"issue":"2","key":"238_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136\u2013142","journal-title":"Mov Disord"},{"issue":"3","key":"238_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"Huntington Study Group","year":"2006","unstructured":"Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66(3):366\u2013372","journal-title":"Neurology"},{"key":"238_CR21","unstructured":"International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington\u2019s Chorea (1994) Neurology Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. 44(8):1533-6"},{"issue":"22","key":"238_CR22","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","volume":"80","author":"A Killoran","year":"2013","unstructured":"Killoran A, Biglan KM, Jankovic J et al (2013) Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology 80(22):2022\u20132027","journal-title":"Neurology"},{"issue":"5","key":"238_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneur.56.5.563","volume":"56","author":"SC Kirkwood","year":"1999","unstructured":"Kirkwood SC, Siemers E, Stout JC et al (1999) Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56(5):563\u2013568","journal-title":"Arch Neurol"},{"key":"238_CR24","unstructured":"Kremer B (2002) Clinical Neurology of Huntington\u2019s disease. In: Bates GP, Harper P, Jones L (eds) Huntington\u2019s disease, 3rd edn. Oxford University Press, Oxford, pp 28\u201353"},{"issue":"2","key":"238_CR25","first-page":"343","volume":"57","author":"B Kremer","year":"1995","unstructured":"Kremer B, Almqvist E, Theilmann J et al (1995) Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet 57(2):343\u2013350","journal-title":"Am J Hum Genet"},{"issue":"4","key":"238_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D et al (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65(4):267\u2013277","journal-title":"Clin Genet"},{"issue":"2","key":"238_CR27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153B","author":"DR Langbehn","year":"2010","unstructured":"Langbehn DR, Hayden MR, Paulsen JS et al (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B(2):397\u2013408","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"238_CR28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","volume":"45","author":"DJ Lanska","year":"1988","unstructured":"Lanska DJ, Lanska MJ, Lavine L et al (1988) Conditions associated with Huntington\u2019s disease at death. A case-control study. Arch Neurol 45(8):878\u2013880","journal-title":"Arch Neurol"},{"issue":"4","key":"238_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ajmg.1320480412","volume":"48","author":"H Lipe","year":"1993","unstructured":"Lipe H, Schultz A, Bird TD (1993) Risk factors for suicide in Huntingtons disease: a retrospective case controlled study. Am J Med Genet 48(4):231\u2013233","journal-title":"Am J Med Genet"},{"key":"238_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.f4c66bd51e8db11f55e1701af937a419","author":"CT Loy","year":"2013","unstructured":"Loy CT, McCusker EA (2013) Is a motor criterion essential for the diagnosis of clinical huntington disease? PLoS Curr. doi:10.1371\/currents.hd.f4c66bd51e8db11f55e1701af937a419","journal-title":"PLoS Curr"},{"issue":"2","key":"238_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1517\/14728210902918299","volume":"14","author":"SL Mason","year":"2009","unstructured":"Mason SL, Barker RA (2009) Emerging drug therapies in Huntington\u2019s disease. Expert Opin Emerg Drugs 14(2):273\u2013297","journal-title":"Expert Opin Emerg Drugs"},{"issue":"8","key":"238_CR32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers RH, Sax DS, Koroshetz WJ et al (1991) Factors associated with slow progression in Huntington\u2019s disease. Arch Neurol 48(8):800\u2013804","journal-title":"Arch Neurol"},{"key":"238_CR33","doi-asserted-by":"publisher","first-page":"c3109","DOI":"10.1136\/bmj.c3109","volume":"340","author":"MJ Novak","year":"2010","unstructured":"Novak MJ, Tabrizi SJ (2010) Huntington\u2019s disease. BMJ 340:c3109","journal-title":"BMJ"},{"key":"238_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1184","author":"M Orth","year":"2010","unstructured":"Orth M, Handley OJ, Schwenke C et al (2010) Observing Huntington\u2019s Disease: the European Huntington\u2019s Disease Network\u2019s REGISTRY. PLoS Curr. doi:10.1371\/currents.RRN1184","journal-title":"PLoS Curr"},{"issue":"12","key":"238_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/jnnp.2010.209668","volume":"82","author":"M Orth","year":"2011","unstructured":"Orth M, Handley OJ, Schwenke C et al (2011) Observing Huntington\u2019s disease: the European Huntington\u2019s Disease Network\u2019s REGISTRY. J Neurol Neurosurg Psychiatry 82(12):1409\u20131412","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"238_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM et al (2001a) Neuropsychiatric aspects of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 71(3):310\u2013314","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"238_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1212\/WNL.57.4.658","volume":"57","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Zhao H, Stout JC et al (2001b) Clinical markers of early disease in persons near onset of Huntington\u2019s disease. Neurology 57(4):658\u2013662","journal-title":"Neurology"},{"issue":"4","key":"238_CR38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/jnp.17.4.496","volume":"17","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Nehl C, Hoth KF et al (2005) Depression and stages of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 17(4):496\u2013502","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"238_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","volume":"162","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Hoth KF, Nehl C et al (2005b) Critical periods of suicide risk in Huntington\u2019s disease. Am J Psychiatry 162(4):725\u2013731","journal-title":"Am J Psychiatry"},{"issue":"8","key":"238_CR40","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","volume":"79","author":"JS Paulsen","year":"2008","unstructured":"Paulsen JS, Langbehn DR, Stout JC et al (2008) Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79(8):874\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"238_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/mds.870050202","volume":"5","author":"JB Penney","year":"1990","unstructured":"Penney JB, Young AB, Shoulson I et al (1990) Huntington\u2019s disease in Venezuela: 7\u00a0years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5(2):93\u201399","journal-title":"Mov Disord"},{"issue":"9750","key":"238_CR42","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/S0140-6736(10)60974-9","volume":"376","author":"M Rawlins","year":"2010","unstructured":"Rawlins M (2010) Huntington\u2019s disease out of the closet? Lancet 376(9750):1372\u20131373","journal-title":"Lancet"},{"issue":"1","key":"238_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5(1):40","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"238_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0033-3182(00)71170-4","volume":"41","author":"A Rosenblatt","year":"2000","unstructured":"Rosenblatt A, Leroi I (2000) Neuropsychiatry of Huntington\u2019s disease and other basal ganglia disorders. Psychosomatics 41(1):24\u201330","journal-title":"Psychosomatics"},{"issue":"1","key":"238_CR45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83\u201398","journal-title":"Lancet Neurol"},{"issue":"3","key":"238_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005053-199303000-00008","volume":"181","author":"JC Rothlind","year":"1993","unstructured":"Rothlind JC, Bylsma FW, Peyser C et al (1993) Cognitive and motor correlates of everyday functioning in early Huntington\u2019s disease. J Nerv Ment Dis 181(3):194\u2013199","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"238_CR47","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R et al (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59(1):16\u201322","journal-title":"Am J Hum Genet"},{"key":"238_CR48","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.me.26.020175.002223","volume":"26","author":"I Shoulson","year":"1975","unstructured":"Shoulson I, Chase TN (1975) Huntington\u2019s disease. Annu Rev Med 26:419\u2013436","journal-title":"Annu Rev Med"},{"issue":"1","key":"238_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29(1):1\u20133","journal-title":"Neurology"},{"issue":"6","key":"238_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1001\/archneur.1996.00550060029011","volume":"53","author":"E Siemers","year":"1996","unstructured":"Siemers E, Foroud T, Bill DJ et al (1996) Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 53(6):487\u2013492","journal-title":"Arch Neurol"},{"issue":"1","key":"238_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/jnnp.69.1.54","volume":"69","author":"S Siesling","year":"2000","unstructured":"Siesling S, Vegter-van de Vlis M, Losekoot M et al (2000) Family history and DNA analysis in patients with suspected Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 69(1):54\u201359","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"238_CR52","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP et al (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 4(4):393\u2013397","journal-title":"Nat Genet"},{"issue":"2","key":"238_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1076\/jcen.24.2.133.998","volume":"24","author":"JS Snowden","year":"2002","unstructured":"Snowden JS, Craufurd D, Thompson J et al (2002) Psychomotor, executive, and memory function in preclinical Huntington\u2019s disease. J Clin Exp Neuropsychol 24(2):133\u2013145","journal-title":"J Clin Exp Neuropsychol"},{"issue":"9","key":"238_CR54","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR et al (2009) Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791\u2013801","journal-title":"Lancet Neurol"},{"issue":"1","key":"238_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A et al (2011) Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31\u201342","journal-title":"Lancet Neurol"},{"issue":"1","key":"238_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RA et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24\u00a0month observational data. Lancet Neurol 11(1):42\u201353","journal-title":"Lancet Neurol"},{"issue":"7","key":"238_CR57","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G et al (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12(7):637\u2013649","journal-title":"Lancet Neurol"},{"issue":"6","key":"238_CR58","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"8","key":"238_CR59","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JM van der Burg","year":"2009","unstructured":"van der Burg JM, Bj\u00f6rkqvist M, Brundin P (2009) Beyond the brain: widespread pathology in Huntington\u2019s disease. Lancet Neurol 8(8):765\u2013774","journal-title":"Lancet Neurol"},{"issue":"4","key":"238_CR60","first-page":"618","volume":"55","author":"IM van der Steenstraten","year":"1994","unstructured":"van der Steenstraten IM, Tibben A, Roos RA et al (1994) Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet 55(4):618\u2013625","journal-title":"Am J Hum Genet"},{"issue":"4","key":"238_CR61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E van Duijn","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19(4):441\u2013448","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"238_CR62","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.parkreldis.2008.10.002","volume":"15","author":"A Videnovic","year":"2009","unstructured":"Videnovic A, Leurgans S, Fan W et al (2009) Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord 15(6):471\u2013474","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"238_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/jmg.27.1.34","volume":"27","author":"L Went","year":"1990","unstructured":"Went L (1990) Ethical issues policy statement on Huntington\u2019s disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet 27(1):34\u201338","journal-title":"J Med Genet"},{"issue":"9734","key":"238_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(10)60957-9","volume":"376","author":"A Wexler","year":"2010","unstructured":"Wexler A (2010) Stigma, history, and Huntington\u2019s disease. Lancet 376(9734):18\u201319","journal-title":"Lancet"},{"issue":"10","key":"238_CR65","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J et al (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci U S A 101(10):3498\u20133503","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"238_CR66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/pn.2007.134585","volume":"7","author":"EJ Wild","year":"2007","unstructured":"Wild EJ, Tabrizi SJ (2007) The differential diagnosis of chorea. Pract Neurol 7(6):360\u2013373","journal-title":"Pract Neurol"},{"issue":"5","key":"238_CR67","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.21915","volume":"23","author":"EJ Wild","year":"2008","unstructured":"Wild EJ, Mudanohwo EE, Sweeney MG et al (2008) Huntington\u2019s disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23(5):716\u2013720","journal-title":"Mov Disord"},{"issue":"12","key":"238_CR68","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/hmg\/2.12.2063","volume":"2","author":"C Z\u00fchlke","year":"1993","unstructured":"Z\u00fchlke C, Riess O, Bockel B et al (1993) Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum Mol Genet 2(12):2063\u20132067","journal-title":"Hum Mol Genet"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2013_238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:04:14Z","timestamp":1674482654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2013_238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783662463437","9783662463444"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/7854_2013_238","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"24 August 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}